Literature DB >> 16214415

The role of stress-response systems for the pathogenesis and progression of MS.

Stefan M Gold1, David C Mohr, Inge Huitinga, Peter Flachenecker, Esther M Sternberg, Christoph Heesen.   

Abstract

Disease progression in multiple sclerosis (MS)--an inflammatory demyelinating and neurodegenerative disease with a presumed T-cell driven autoimmune origin--has long been hypothesized to be associated with stress. However, this notion has only recently been supported by prospective clinical studies. Several clinical and molecular studies in MS and its animal models have recently shown disruptions in the communication between the immune system and the two major stress response systems, the hypothalamo-pituitary-adrenal (HPA) axis and the autonomic nervous system. Insensitivity to glucocorticoid and beta-adrenergic modulation might be involved in overshooting inflammation in MS, whereas hyperactivity of the HPA axis has been linked to neurodegeneration and increased disability. Here, we integrate findings from molecular, cellular, experimental, clinical and epidemiological research to describe the involvement of stress response systems in MS pathogenesis and progression.

Entities:  

Mesh:

Year:  2005        PMID: 16214415     DOI: 10.1016/j.it.2005.09.010

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  32 in total

Review 1.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

2.  Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms.

Authors:  Stefan M Gold; Kyle C Kern; Mary-Frances O'Connor; Michael J Montag; Aileen Kim; Ye S Yoo; Barbara S Giesser; Nancy L Sicotte
Journal:  Biol Psychiatry       Date:  2010-06-19       Impact factor: 13.382

3.  Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis.

Authors:  Annett Apel; Brigitte Greim; Nicolaus König; Uwe K Zettl
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

Review 4.  Stress and multiple sclerosis.

Authors:  David C Mohr
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

5.  Stress and the risk of multiple sclerosis.

Authors:  T Riise; D C Mohr; K L Munger; J W Rich-Edwards; I Kawachi; A Ascherio
Journal:  Neurology       Date:  2011-05-31       Impact factor: 9.910

Review 6.  Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction.

Authors:  Marni N Silverman; Esther M Sternberg
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

7.  The effect of repeated restraint stress in pain-related behavior induced by nucleus pulposus applied on the nerve root in rats.

Authors:  Kazuhide Uesugi; Miho Sekiguchi; Shin-ichi Kikuchi; Shin-ichi Konno
Journal:  Eur Spine J       Date:  2011-06-23       Impact factor: 3.134

8.  Stress-induced brain activity, brain atrophy, and clinical disability in multiple sclerosis.

Authors:  Martin Weygandt; Lil Meyer-Arndt; Janina Ruth Behrens; Katharina Wakonig; Judith Bellmann-Strobl; Kerstin Ritter; Michael Scheel; Alexander U Brandt; Christian Labadie; Stefan Hetzer; Stefan M Gold; Friedemann Paul; John-Dylan Haynes
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

Review 9.  Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Semin Immunopathol       Date:  2016-08-08       Impact factor: 9.623

10.  Stress exacerbates neuropathic pain via glucocorticoid and NMDA receptor activation.

Authors:  Jessica K Alexander; A Courtney DeVries; Kristina A Kigerl; Jason M Dahlman; Phillip G Popovich
Journal:  Brain Behav Immun       Date:  2009-04-08       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.